Skip to main content
. 2018 Mar 9;97(10):e0097. doi: 10.1097/MD.0000000000010097

Figure 2.

Figure 2

Forest plots for predictive analyses in trials comparing chemotherapy plus EGFR antibody therapy with chemotherapy alone in RAS/BRAF wild patients. (A) progression-free survival, (B) overall survival. CI = confidence interval, CT = chemotherapy, EGFR = epidermal growth factor receptor, HR = hazard ratio, OR = odds ratio.